Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Ethnic differences in insulin action in obese African-American and Latino adolescents.

Hasson RE, Adam TC, Davis JN, Weigensberg MJ, Ventura EE, Lane CJ, Roberts CK, Goran MI.

J Clin Endocrinol Metab. 2010 Aug;95(8):4048-51. doi: 10.1210/jc.2010-0018. Epub 2010 May 5.

2.

A feed-forward loop amplifies nutritional regulation of PNPLA3.

Huang Y, He S, Li JZ, Seo YK, Osborne TF, Cohen JC, Hobbs HH.

Proc Natl Acad Sci U S A. 2010 Apr 27;107(17):7892-7. doi: 10.1073/pnas.1003585107. Epub 2010 Apr 12.

3.

Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease.

Valenti L, Al-Serri A, Daly AK, Galmozzi E, Rametta R, Dongiovanni P, Nobili V, Mozzi E, Roviaro G, Vanni E, Bugianesi E, Maggioni M, Fracanzani AL, Fargion S, Day CP.

Hepatology. 2010 Apr;51(4):1209-17. doi: 10.1002/hep.23622.

PMID:
20373368
4.

The expression level of non-alcoholic fatty liver disease-related gene PNPLA3 in hepatocytes is highly influenced by hepatic lipid status.

Hoekstra M, Li Z, Kruijt JK, Van Eck M, Van Berkel TJ, Kuiper J.

J Hepatol. 2010 Feb;52(2):244-51. doi: 10.1016/j.jhep.2009.11.004. Epub 2009 Nov 24.

PMID:
20015565
5.

Variant in PNPLA3 is associated with alcoholic liver disease.

Tian C, Stokowski RP, Kershenobich D, Ballinger DG, Hinds DA.

Nat Genet. 2010 Jan;42(1):21-3. doi: 10.1038/ng.488. Epub 2009 Nov 29.

PMID:
19946271
6.

Comparison of fat-water MRI and single-voxel MRS in the assessment of hepatic and pancreatic fat fractions in humans.

Hu HH, Kim HW, Nayak KS, Goran MI.

Obesity (Silver Spring). 2010 Apr;18(4):841-7. doi: 10.1038/oby.2009.352. Epub 2009 Oct 15.

7.

A nonsynonymous gene variant in the adiponutrin gene is associated with nonalcoholic fatty liver disease severity.

Sookoian S, Castaño GO, Burgueño AL, Gianotti TF, Rosselli MS, Pirola CJ.

J Lipid Res. 2009 Oct;50(10):2111-6. doi: 10.1194/jlr.P900013-JLR200.

8.

Genetic evidence for a role of adiponutrin in the metabolism of apolipoprotein B-containing lipoproteins.

Kollerits B, Coassin S, Beckmann ND, Teumer A, Kiechl S, Döring A, Kavousi M, Hunt SC, Lamina C, Paulweber B, Kutalik Z, Nauck M, van Duijn CM, Heid IM, Willeit J, Brandstätter A, Adams TD, Mooser V, Aulchenko YS, Völzke H, Kronenberg F.

Hum Mol Genet. 2009 Dec 1;18(23):4669-76. doi: 10.1093/hmg/ddp424. Epub 2009 Sep 3.

9.

Dissociation between fatty liver and insulin resistance in humans carrying a variant of the patatin-like phospholipase 3 gene.

Kantartzis K, Peter A, Machicao F, Machann J, Wagner S, Königsrainer I, Königsrainer A, Schick F, Fritsche A, Häring HU, Stefan N.

Diabetes. 2009 Nov;58(11):2616-23. doi: 10.2337/db09-0279. Epub 2009 Aug 3.

10.

Type 2 diabetes in children and adolescents.

Weigensberg MJ, Goran MI.

Lancet. 2009 May 23;373(9677):1743-4. doi: 10.1016/S0140-6736(09)60961-2. Review. No abstract available.

PMID:
19465216
11.

Randomized control trial to improve adiposity and insulin resistance in overweight Latino adolescents.

Davis JN, Kelly LA, Lane CJ, Ventura EE, Byrd-Williams CE, Alexandar KA, Azen SP, Chou CP, Spruijt-Metz D, Weigensberg MJ, Berhane K, Goran MI.

Obesity (Silver Spring). 2009 Aug;17(8):1542-8. doi: 10.1038/oby.2009.19. Epub 2009 Feb 26.

12.

A common variant in PNPLA3, which encodes adiponutrin, is associated with liver fat content in humans.

Kotronen A, Johansson LE, Johansson LM, Roos C, Westerbacka J, Hamsten A, Bergholm R, Arkkila P, Arola J, Kiviluoto T, Fisher RM, Ehrenborg E, Orho-Melander M, Ridderstråle M, Groop L, Yki-Järvinen H.

Diabetologia. 2009 Jun;52(6):1056-60. doi: 10.1007/s00125-009-1285-z. Epub 2009 Feb 18.

PMID:
19224197
13.

Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease.

Romeo S, Kozlitina J, Xing C, Pertsemlidis A, Cox D, Pennacchio LA, Boerwinkle E, Cohen JC, Hobbs HH.

Nat Genet. 2008 Dec;40(12):1461-5. doi: 10.1038/ng.257. Epub 2008 Sep 25.

14.

High visceral and low abdominal subcutaneous fat stores in the obese adolescent: a determinant of an adverse metabolic phenotype.

Taksali SE, Caprio S, Dziura J, Dufour S, Calí AM, Goodman TR, Papademetris X, Burgert TS, Pierpont BM, Savoye M, Shaw M, Seyal AA, Weiss R.

Diabetes. 2008 Feb;57(2):367-71. Epub 2007 Oct 31.

15.

Prevalence of fatty liver in children and adolescents.

Schwimmer JB, Deutsch R, Kahen T, Lavine JE, Stanley C, Behling C.

Pediatrics. 2006 Oct;118(4):1388-93.

PMID:
17015527
16.

Hepatic fat fraction: MR imaging for quantitative measurement and display--early experience.

Hussain HK, Chenevert TL, Londy FJ, Gulani V, Swanson SD, McKenna BJ, Appelman HD, Adusumilli S, Greenson JK, Conjeevaram HS.

Radiology. 2005 Dec;237(3):1048-55. Epub 2005 Oct 19. Erratum in: Radiology. 2006 Mar;238(3):1078.

PMID:
16237138
17.

Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity.

Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, Grundy SM, Hobbs HH.

Hepatology. 2004 Dec;40(6):1387-95.

PMID:
15565570
18.

Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population.

Szczepaniak LS, Nurenberg P, Leonard D, Browning JD, Reingold JS, Grundy S, Hobbs HH, Dobbins RL.

Am J Physiol Endocrinol Metab. 2005 Feb;288(2):E462-8. Epub 2004 Aug 31.

19.

The metabolic syndrome in overweight Hispanic youth and the role of insulin sensitivity.

Cruz ML, Weigensberg MJ, Huang TT, Ball G, Shaibi GQ, Goran MI.

J Clin Endocrinol Metab. 2004 Jan;89(1):108-13.

PMID:
14715836
20.

SNP genotyping by the 5'-nuclease reaction.

Livak KJ.

Methods Mol Biol. 2003;212:129-47. No abstract available.

PMID:
12491907

Supplemental Content

Support Center